Hiroshi Kuriki
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 6
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 4
- Hepatology top 10%
- Liver physiology and pathology 4
- Toxicology top 10%
- Gastroenterology top 10%
-
- Cancer Genomics and Diagnostics 4
-
- Pediatric Hepatobiliary Diseases and Treatments 3
- Co-authors
- David R. SpigelShonen YoshidaJacek JassemFilippo de MarinisSimonetta MocciRoy S. HerbstKazuhiko NakagawaTomohide Tamura
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Hiroshi Kuriki
32 papers receiving 839 citations
Peers
Comparison fields: 5 of 68
- Oncology 524
- Pulmonary and Respiratory Medicine 480
- Hepatology 86
- Toxicology 32
- Gastroenterology 35
Countries citing papers authored by Hiroshi Kuriki
This map shows the geographic impact of Hiroshi Kuriki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kuriki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kuriki more than expected).
Fields of papers citing papers by Hiroshi Kuriki
This network shows the impact of papers produced by Hiroshi Kuriki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kuriki. The network helps show where Hiroshi Kuriki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Kuriki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 114 | |
| 2 | 2021 | 4 | |
| 3 | 2021 | 6 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 11 | |
| 8 | 2018 | 57 | |
| 9 | 2017 | 4 | |
| 10 | 2017 | 22 | |
| 11 | 2017 | 23 | |
| 12 | 2017 | 52 | |
| 13 | 2016 | 60 | |
| 14 | 2015 | 39 | |
| 15 | 2014 | 12 | |
| 16 | 1999 | 0 | |
| 17 | 1992 | 46 | |
| 18 | 1992 | 27 | |
| 19 | 1991 | 13 | |
| 20 | 1991 | 19 |
About Hiroshi Kuriki
Hiroshi Kuriki is a scholar working on Toxicology, Oncology and Hepatology, having authored 34 papers that have together received 852 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Research Studies (6 papers), Liver physiology and pathology (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). The work is most often cited by research in Oncology (524 citations), Pulmonary and Respiratory Medicine (480 citations) and Hepatology (86 citations). Hiroshi Kuriki has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include David R. Spigel, Shonen Yoshida, Jacek Jassem, Filippo de Marinis, Simonetta Mocci, Roy S. Herbst, Kazuhiko Nakagawa, Tomohide Tamura, Makoto Nishio and Ida Enquist. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.